Editors act in accordance with COPE rules in the face of allegations and suspicions of larceny, not showing the citations correctly, and data fraud allegations regarding the work submitted to the journal. Plagiarism (larceny) is regardless of whether it is intentional or not, it is considered an ethical violation. It is unacceptable, as the work is similar to other sources, being unreferenced and published in this form is unethical, as well as being a crime. Therefore, in accordance with the JHNM publication policy, plagiarism inspection is mandatory for all studies to be published. In this context, all studies submitted to the journal are evaluated through the Turnitin or iThenticate software after the double-blind review is completed. An audit is carried out by a team of experts based on criteria other than the percentage rate, such as the percentage of matching criteria, the matching paragraphs, the correct references and ascriptions, where the matching locations in the article is, the source of the study, etc. Prepared plagiarism report is evaluated by journal editor. According to this report, the author may be asked to correct the errors in the manuscript and resend it, as well the manuscript can be accepted or rejected. The final decision on whether to accept the study in this process belongs to the editor. All manuscript that do not comply with these standards are is taken out of publication. This is also valid for manuscript that are determined as possible illegal or containing nonconformities after the publication.
HUMAN AND ANIMAL RIGHTS, INFORMED
JHNM maintains that the articles it publishes must be at the best ethical and scientific standards, free from commercial concerns. The compliance of the articles with the ethical rules falls under the responsibility of the authors.
In this context, it should be stated that the ethical principles regarding the subjects participating in the clinical trials are followed in the articles sent to be published in the journal. In addition, approval letters from local or national ethical committees required depending on the type of experiment should be sent with the letter. However, a document signed by all authors should be sent to the editor, together with a letter stating that they have received written informed consent from the participant / patients or their guardians. Attention is given to not publish the patient's name, their initials or descriptive information such as register numbers, photographs and family tree information, etc. unless they are necessary for scientific purposes, where receiving a letter from patients stating that they were advised.
Especially in case reports, descriptive details about the patient should be obtained only it is necessary. For example, if the masking of the eye area in photographs is not enough to hide the identity, or if the data has been changed to hide the credentials, the authors should assure that these changes do not affect the scientific significance.
In case reports “Informed Consent” should be obtained from the patients and it should be stated in the article. In the presence of such studies, the authors must state in the METHOD section of the manuscript that they have conducted the study in accordance with the required principles and that they have received “Informed Consent” from the ethics committees and from the people who participated in the study.
In the manuscript, if there is a direct or indirect commercial connection or financial support institution for the study, the authors should state in the section before the referances page hat there is no commercial relationship with the commercial product, drug, pharmaceutical company, etc. or if there is, how this relationship is (consultant, other agreements).